144 related articles for article (PubMed ID: 9342170)
1. Overview: pharmacokinetic drug-drug interactions.
Li AP; Jurima-Romet M
Adv Pharmacol; 1997; 43():1-6. PubMed ID: 9342170
[No Abstract] [Full Text] [Related]
2. Interactions and drug-metabolizing enzymes.
Ciummo PE; Katz NL
Am Pharm; 1995 Sep; NS35(9):41-51; quiz 51-3. PubMed ID: 7484817
[No Abstract] [Full Text] [Related]
3. Application of human liver microsomes in metabolism-based drug-drug interactions: in vitro-in vivo correlations and the Abbott Laboratories experience.
Rodrigues AD; Wong SL
Adv Pharmacol; 1997; 43():65-101. PubMed ID: 9342173
[No Abstract] [Full Text] [Related]
4. Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors.
Rendic S; Di Carlo FJ
Drug Metab Rev; 1997; 29(1-2):413-580. PubMed ID: 9187528
[No Abstract] [Full Text] [Related]
5. FK 506 metabolism in human liver microsomes: investigation of the involvement of cytochrome P450 isozymes other than CYP3A4.
Karanam BV; Vincent SH; Newton DJ; Wang RW; Chiu SH
Drug Metab Dispos; 1994; 22(5):811-4. PubMed ID: 7530623
[No Abstract] [Full Text] [Related]
6. Primary hepatocyte cultures as an in vitro experimental model for the evaluation of pharmacokinetic drug-drug interactions.
Li AP
Adv Pharmacol; 1997; 43():103-30. PubMed ID: 9342174
[No Abstract] [Full Text] [Related]
7. Pharmacokinetic drug interactions involving 17alpha-ethinylestradiol: a new look at an old drug.
Zhang H; Cui D; Wang B; Han YH; Balimane P; Yang Z; Sinz M; Rodrigues AD
Clin Pharmacokinet; 2007; 46(2):133-57. PubMed ID: 17253885
[TBL] [Abstract][Full Text] [Related]
8. Metabolism profiling, and cytochrome P450 inhibition & induction in drug discovery.
Yan Z; Caldwell GW
Curr Top Med Chem; 2001 Nov; 1(5):403-25. PubMed ID: 11899105
[TBL] [Abstract][Full Text] [Related]
9. Use of in vitro human metabolism studies in drug development. An industrial perspective.
Rodrigues AD
Biochem Pharmacol; 1994 Dec; 48(12):2147-56. PubMed ID: 7811296
[No Abstract] [Full Text] [Related]
10. Cytochrome P-450 drug interactions and the selective serotonin reuptake inhibiting antidepressants.
Caley CF; Silvia RJ
Conn Med; 2000 Dec; 64(12):721-4. PubMed ID: 11210325
[No Abstract] [Full Text] [Related]
11. Involvement of cytochrome P-450 isozymes in melatonin metabolism and clinical implications.
Yeleswaram K; Vachharajani N; Santone K
J Pineal Res; 1999 Apr; 26(3):190-1. PubMed ID: 10231734
[No Abstract] [Full Text] [Related]
12. Clinically important pharmacokinetic drug-drug interactions: role of cytochrome P450 enzymes.
Tanaka E
J Clin Pharm Ther; 1998 Dec; 23(6):403-16. PubMed ID: 10048501
[TBL] [Abstract][Full Text] [Related]
13. Preclinical approach for identifying drug interactions.
Kamataki T; Yokoi T; Fujita K; Ando Y
Cancer Chemother Pharmacol; 1998; 42 Suppl():S50-3. PubMed ID: 9750029
[TBL] [Abstract][Full Text] [Related]
14. [Interaction of antifungals with other drugs: clinical significance].
Semenov SN; Chilova RA; Dmitriev VA; Anikin GS; Sychev DA; Kukes VG
Antibiot Khimioter; 2008; 53(7-8):40-3. PubMed ID: 19227124
[No Abstract] [Full Text] [Related]
15. Competition between cytochrome P-450 isozymes for NADPH-cytochrome P-450 oxidoreductase affects drug metabolism.
Li DN; Pritchard MP; Hanlon SP; Burchell B; Wolf CR; Friedberg T
J Pharmacol Exp Ther; 1999 May; 289(2):661-7. PubMed ID: 10215637
[TBL] [Abstract][Full Text] [Related]
16. Human drug metabolism and the cytochromes P450: application and relevance of in vitro models.
Venkatakrishnan K; Von Moltke LL; Greenblatt DJ
J Clin Pharmacol; 2001 Nov; 41(11):1149-79. PubMed ID: 11697750
[TBL] [Abstract][Full Text] [Related]
17. Induction and suppression of cytochrome P450 isoenzymes and generation of oxygen radicals by procymidone in liver, kidney and lung of CD1 mice.
Sapone A; Affatato A; Canistro D; Broccoli M; Trespidi S; Pozzetti L; Biagi GL; Cantelli-Forti G; Paolini M
Mutat Res; 2003 Jun; 527(1-2):67-80. PubMed ID: 12787915
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of terfenadine metabolism. Pharmacokinetic and pharmacodynamic consequences.
Kivistö KT; Neuvonen PJ; Klotz U
Clin Pharmacokinet; 1994 Jul; 27(1):1-5. PubMed ID: 7955768
[No Abstract] [Full Text] [Related]
19. Drug interactions.
Med Lett Drugs Ther; 1999 Jul; 41(1056):61-2. PubMed ID: 10436770
[No Abstract] [Full Text] [Related]
20. Clinically significant cytochrome P-450 drug interactions--a comment.
Ford NF; Sonnichsen DS
Pharmacotherapy; 1998; 18(4):890-1; discussion 892-3. PubMed ID: 9692671
[No Abstract] [Full Text] [Related]
[Next] [New Search]
